ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.37
0.61%
US Tech 100
21,153.20
-0.50%
다우존스 지수
44,156.73
0.30%
Bitcoin
102,358.87
-1.23%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Inhibrx Biosciences Inc (INBX)

  7. Inhibrx Biosciences Inc (INBX) 뉴스

INBX

Inhibrx Biosciences (INBX)

Inhibrx Biosciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:INBX
일자시간출처헤드라인심볼기업
2025/01/2207:01PR Newswire (US)Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal CancerNASDAQ:INBXInhibrx Biosciences Inc
2025/01/1406:15PR Newswire (US)Inhibrx Biosciences Announces Loan Agreement with Oxford FinanceNASDAQ:INBXInhibrx Biosciences Inc
2024/11/1506:24PR Newswire (US)Inhibrx Biosciences Reports Third Quarter 2024 Financial ResultsNASDAQ:INBXInhibrx Biosciences Inc
2024/11/0506:00PR Newswire (US)Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and InnovationNASDAQ:INBXInhibrx Biosciences Inc
2024/08/1407:54PR Newswire (US)Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:INBXInhibrx Biosciences Inc
2024/06/0105:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3107:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:34Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:34Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:32Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:INBXInhibrx Biosciences Inc
2024/05/3105:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2905:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2507:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2505:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2505:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2505:00PR Newswire (US)Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to SanofiNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2222:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/2110:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
2024/05/1806:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/1805:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
2024/05/1107:36PR Newswire (US)Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-OffNASDAQ:INBXInhibrx Biosciences Inc
2024/05/1005:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/0905:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/05/0905:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
2024/05/0905:37PR Newswire (US)Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated MergerNASDAQ:INBXInhibrx Biosciences Inc
2024/05/0706:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/1205:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
2024/03/0906:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
 검색 관련기사 보기:NASDAQ:INBX

최근 히스토리

AMEX
XLF
Financial Select Sector
NYSE
BAC
Bank of America
FX
USDJPY
US Dollar vs Yen
SPI
SP500
S&P 500
AMEX
XLE
Energy Select Sector SPDR
COIN
XRPUSD
Ripple
NYSE
CVX
Chevron
USOTC
RHHBY
Roche (QX)
NASDAQ
AMZN
Amazon.com
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
COIN
ADAUSD
Cardano
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유